These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
639 related items for PubMed ID: 9439479
1. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. Tertov VV, Orekhov AN. Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479 [Abstract] [Full Text] [Related]
2. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions. Tertov VV, Bittolo-Bon G, Sobenin IA, Cazzolato G, Orekhov AN, Avogaro P. Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720 [Abstract] [Full Text] [Related]
9. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells. Fager G, Camejo G, Olsson U, Ostergren-Lundén G, Lustig F, Bondjers G. J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380 [Abstract] [Full Text] [Related]
10. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein. Tertov VV, Sobenin IA, Orekhov AN. Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495 [Abstract] [Full Text] [Related]
11. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway. Limor R, Kaplan M, Sawamura T, Sharon O, Keidar S, Weisinger G, Knoll E, Naidich M, Stern N. Am J Hypertens; 2005 Mar; 18(3):299-307. PubMed ID: 15797645 [Abstract] [Full Text] [Related]
15. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein. Alexander JJ, Lewis I. J Surg Res; 2002 Mar; 103(1):41-6. PubMed ID: 11855916 [Abstract] [Full Text] [Related]
16. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. Brown BE, Rashid I, van Reyk DM, Davies MJ. FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204 [Abstract] [Full Text] [Related]
17. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Tertov VV, Kaplun VV, Sobenin IA, Orekhov AN. Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784 [Abstract] [Full Text] [Related]
18. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. Lin SJ, Yen HT, Chen YH, Ku HH, Lin FY, Chen YL. J Cell Biochem; 2003 Mar 01; 88(4):836-47. PubMed ID: 12577317 [Abstract] [Full Text] [Related]
19. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits. Shiomi M, Ito T, Tsukada T, Shiraishi M, Yata T. Arzneimittelforschung; 1998 Jun 01; 48(6):680-5. PubMed ID: 9689427 [Abstract] [Full Text] [Related]